New Safety Data Suggests SPRAVATO®▽ (Esketamine Nasal Spray) is More Tolerable and Effective Compared to Quetiapine Extended-Release (XR) in Adults with Treatment-resistant Major Depressive Disorder
Spravato, INN-esketamine
SPRAVATO®▽ (Esketamine) Nasal Spray Approved in Europe for Adults with Treatment-Resistant Major Depressive Disorder | Business Wire
Full article: Practical recommendations for the management of treatment-resistant depression with esketamine nasal spray therapy: Basic science, evidence-based knowledge and expert guidance
Psychedelic Bulletin #125: New Data Boosts Spravato's Case; Bipartisan Breakthrough Therapies Act; Berkeley Could Decrim. Psychedelics; DEA Increases Production Quotas - Psychedelic Alpha
Bidose Nasal Spray Device | Aptar BDS | Nasal Spray Manufacturers
Find a Certified SPRAVATO® Treatment Center | SPRAVATO® (esketamine) Nasal Spray
Population Pharmacokinetics of Esketamine Nasal Spray and its Metabolite Noresketamine in Healthy Subjects and Patients with Treatment-Resistant Depression | SpringerLink
Package leaflet: Information for the patient Spravato 28 mg nasal spray, solution esketamine This medicine is subject to additio
Spravato, INN-esketamine
Effect of Esketamine Nasal Spray on Olfactory Function and Nasal Tolerability in Patients with Treatment-Resistant Depression: Results from Four Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase III Studies | CNS Drugs
Spravato, INN-esketamine
Efficacy and Safety of Flexibly Dosed Esketamine Nasal Spray Combined With a Newly Initiated Oral Antidepressant in Treatment-Resistant Depression: A Randomized Double-Blind Active-Controlled Study | American Journal of Psychiatry
SPRAVATO®▽ (Esketamine Nasal Spray) Authorised in Europe for the Rapid Reduction of Depressive Symptoms in a Psychiatric Emergency for Patients with Major Depressive Disorder | Business Wire
Approval of esketamine for treatment-resistant depression - The Lancet Psychiatry
Package leaflet: Information for the patient Spravato 28 mg nasal spray, solution esketamine This medicine is subject to additio
SPRAVATO®▽ (Esketamine) Nasal Spray Approved in Europe for Adults with Treatment-Resistant Major Depressive Disorder | Business Wire
Esketamine nasal spray that may be able to improve depression in those with suicidal thoughts approved by the FDA' | The US Sun
.jpg "Janssen's Esketamine Nasal Spray Which Is Similar To the Illegal Opioid Ketamine Gets Approved in the EU - Thailand Medical News")
Janssen's Esketamine Nasal Spray Which Is Similar To the Illegal Opioid Ketamine Gets Approved in the EU - Thailand Medical News
Pronunciation of the word(s) "Spravato Nasal Spray". - YouTube
Find a Certified SPRAVATO® Treatment Center | SPRAVATO® (esketamine) Nasal Spray
Esketamine Nasal Spray versus Quetiapine for Treatment-Resistant Depression | NEJM
211243Orig1s000
